Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cardiovasc Toxicol ; 24(6): 527-538, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38720122

ABSTRACT

Adolescents commonly co-abuse many drugs including anabolic androgenic steroids either they are athletes or non-athletes. Stanozolol is the major anabolic used in recent years and was reported grouped with cannabis. The current study aimed at evaluating the biochemical and histopathological changes related to the hypertrophic effects of stanozolol and/or cannabis whether in condition of exercise practice or sedentary conditions. Adult male Wistar albino rats received either stanozolol (5 mg/kg, s.c), cannabis (10 mg/kg, i.p.), and a combination of both once daily for two months. Swimming exercise protocol was applied as a training model. Relative heart weight, oxidative stress biomarkers, cardiac tissue fibrotic markers were evaluated. Left ventricular morphometric analysis and collagen quantification was done. The combined treatment exhibited serious detrimental effects on the heart tissues. It increased heart tissue fibrotic markers (Masson's trichrome stain (p < 0.001), cardiac COL3 (p < 0.0001), and VEGF-A (p < 0.05)), lowered heart glutathione levels (p < 0.05) and dramatically elevated oxidative stress (increased malondialdehyde (p < 0.0001) and 8-OHDG (p < 0.0001)). Training was not ameliorating for the observed effects. Misuse of cannabis and stanozolol resulted in more hypertrophic consequences of the heart than either drug alone, which were at least largely assigned to oxidative stress, heart tissue fibrotic indicators, histological alterations, and morphometric changes.


Subject(s)
Anabolic Agents , Cardiomegaly, Exercise-Induced , Fibrosis , Oxidative Stress , Rats, Wistar , Stanozolol , Animals , Stanozolol/toxicity , Male , Oxidative Stress/drug effects , Anabolic Agents/toxicity , Cardiomegaly, Exercise-Induced/drug effects , Hypertrophy, Left Ventricular/physiopathology , Hypertrophy, Left Ventricular/chemically induced , Hypertrophy, Left Ventricular/metabolism , Hypertrophy, Left Ventricular/pathology , Hypertrophy, Left Ventricular/prevention & control , Ventricular Remodeling/drug effects , Myocardium/pathology , Myocardium/metabolism , Doping in Sports , Biomarkers/metabolism , Swimming , Physical Conditioning, Animal/physiology , Rats , Disease Models, Animal
SELECTION OF CITATIONS
SEARCH DETAIL